A Case of Chagas Cardiomyopathy in Western Virginia: Worlds Away?

Kiriti Vattikonda1, Christopher J Peterson1, Benjamin Mulkey2

  • 1Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, USA.

Cureus
|August 21, 2023
PubMed

Insights

Chagas cardiomyopathy, a heart condition from the Trypanosoma cruzi parasite, affects people globally. This case highlights its presence in the US, even in non-endemic areas, emphasizing the need for awareness in cardiac patients with relevant travel history.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Parasitology

Background:

  • Chagas cardiomyopathy is a major cause of heart disease globally, primarily linked to Trypanosoma cruzi infection.
  • While endemic to Latin America, Chagas disease awareness is crucial in the United States due to population migration.
  • Cardiac abnormalities like heart block can be indicators of Chagas disease in at-risk individuals.

Observation:

  • A case of Chagas cardiomyopathy is presented in a patient residing in Virginia.
  • The patient had a prior residence in Mexico, an area endemic for Chagas disease.
  • This diagnosis was made despite the patient living in a non-endemic region of the US.

Findings:

  • The diagnosis of Chagas cardiomyopathy was confirmed in a Virginia resident with a history of living in Mexico.
  • This case underscores the potential for Trypanosoma cruzi infection to manifest as cardiac pathology in the US.
  • Diagnostic consideration is warranted for patients presenting with cardiac issues and relevant geographical exposure.

Implications:

  • Increased awareness of Chagas cardiomyopathy is needed among US healthcare providers, particularly for patients with cardiac symptoms and travel/residence history in endemic regions.
  • Early diagnosis and management of Chagas cardiomyopathy can potentially improve patient outcomes and prevent severe cardiac complications.
  • This case contributes to understanding the geographical spread and clinical presentation of Chagas disease in non-endemic settings.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16